Posts by Sandra Ansanay-Alex
Défi Source 2023 rewards 6 innovative projects focusing on people and society
Over 150 innovation and healthcare players attended the presentations of the 12 finalist projects during the finale of the second edition of Défi Source, at the Institut et Haute École de la Santé La Source in Lausanne. 8 prizes were awarded to the most innovative projects. The winning projects The Prix du Jury…
Read MoreDewi, DNAQuraCy, naialabs and MagFlow awarded grants from FIT
The FIT, (Fondation pour l’Innovation Technologique) in canton of Vaud awarded 4 promising Swiss Health Valley projects. DNAQuraCy spun out of UNIL/CHUV and works on the next generation DNA sequencing tools. The three other projects are spin-offs from EPFL: Dewi anticipates anxiety attacks through neuroscience, naialabs allows at-home blood testing and MagFlow is miniaturizing microcatheters.…
Read MoreIsospec Analytics wins CHF 150’000 and Venture Kick’s 3rd round
The startup uses molecular signatures that can be used like bar codes to identify molecules, and developed a technology to measure them in a fast and reliable way, digitizing molecular structure, and greatly simplifying identification processes. This technology is key for the development of precision medicine. The molecular structure of a compound plays…
Read MoreA HUG patient saved by natural viruses called bacteriophages
For the first time, a multidisciplinary team from the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE) has successfully treated a patient suffering from an antibiotic-resistant chronic bacterial lung infection using bacteriophages. This Swiss first was achieved thanks to a highly personalised, multidisciplinary approach involving the selection of a bacteriophage (a…
Read MoreEBAMed raises EUR 14.35 Million in Series A Funding
The Swiss Health Valley start-up develops a novel image guidance system for the non-invasive treatment of Ventricular Tachycardia through Proton Therapy EBAMed SA, a Geneva-based company specializing in the development of novel image guidance systems for ventricular arrhythmias, announced today the raising of 14.35 M € in Series A Funding to accelerate the…
Read More>>venture>> Startup Competition: Diatheris and ZiZAN!A Biobotanica awarded
Several Swiss Health Valley projects were rewarded during the finale of the >>venture>> Startup Competition on 26 June 2023, at the SwissTech Convention Center. BioSimo : Grand Prize (ZH) Biosimo has been awarded with CHF 150,000 and a McKinsey & Company business consulting package to keep venturing forward successfully. This Zürich-based chemical engineering…
Read MoreDebiopharm invests $6 Million with Benchstrength in Altis Labs
Altis Labs is a Canadian computational imaging company accelerating clinical trials with artificial intelligence. “We are thrilled to partner with Benchstrength and Debiopharm,” said Felix Baldauf-Lenschen, Co-Founder and CEO of Altis. “This partnership will help us execute on our mission to reduce the excessive time and cost it takes to bring novel, effective treatments to patients…
Read MoreBloom Renewables won the Prix Sud
Le Temps, and its main partner Romande Energie, announced the Sustainable Start-Up 2023 Prize Bloom Biorenewables, a Fribourg based start-up, transforms plants (biomass) into energy and renewable materials with the goal to replace petroleum in perfumes, textiles and plastics. Its technology makes it possible to harness the potential of plant by-products such as straw…
Read MoreLunaphore Technologies to get acquired by Bio-Techne
Lunaphore Technologies SA, a Vaud-based (Switzerland) life sciences company developing technology to enable spatial biology in every laboratory, announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a USA-based global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to…
Read MoreThe ERAS protocol, developed at the CHUV, receives the “Nobel Prize for Surgery”
Under the guidance of its Director General Nicolas Demartines, the CHUV was the first hospital in Switzerland to adopt the “enhanced recovery after surgery” (ERAS), an innovation developed by Danish doctor Henrik Kehlet that has made a major contribution to improving the lives of patients after surgery, as well as reducing costs. The protocol just…
Read More